MedSwitcher
GLP-1 Resource Hub

GLP-1 Guides, Comparisons, and Switching Help

If you are comparing GLP-1 medications, switching from one drug to another, or trying to understand cost and side effects, start here. This page links the highest-intent resources across MedSwitcher.

Top comparisons
Foundayo vs Wegovy
Head-to-head comparison of Foundayo (orforglipron) vs Wegovy (semaglutide). Compare weight loss, cost, side effects, convenience, and which is better for you.
Foundayo vs Zepbound
Compare Foundayo (orforglipron pill) vs Zepbound (tirzepatide injection). Both from Eli Lilly — which is better for weight loss, cost, and convenience?
Foundayo vs Ozempic
Compare Foundayo (orforglipron) vs Ozempic (semaglutide). Pill vs injection, cost, weight loss, side effects — which GLP-1 is better in 2026?
Foundayo vs Rybelsus
Compare Foundayo (orforglipron) vs Rybelsus (oral semaglutide). Both are GLP-1 pills, but with very different convenience, cost, and efficacy profiles.
Foundayo vs Wegovy Pill
Compare Foundayo vs Wegovy Pill — two oral GLP-1s for weight loss. See how they differ on efficacy, convenience, cost, and side effects in 2026.
Zepbound vs Wegovy
Zepbound vs Wegovy head-to-head comparison. SURMOUNT-5 data, cost, cardiovascular evidence, side effects, and which GLP-1 injection wins in 2026.
Wegovy Pill vs Injection
Wegovy pill vs Wegovy injection — same semaglutide molecule, vastly different experience. Compare cost, efficacy, convenience, and how to switch forms.
Zepbound vs Mounjaro
Zepbound vs Mounjaro explained — same tirzepatide molecule, different FDA approvals. Learn about indications, insurance coverage, and switching.
Foundayo vs Compounded
Foundayo vs compounded semaglutide — compare cost, safety, quality, and legality. Learn why FDA-approved GLP-1s are the safer choice in 2026.
CagriSema vs Zepbound
CagriSema vs Zepbound comparison. Weight loss (22.7% vs 22.5%), mechanism, cost outlook, and which next-gen GLP-1 injection to choose.
Retatrutide vs Zepbound
Retatrutide vs Zepbound: triple agonist (28.7% weight loss) vs dual agonist (22.5%). Phase 3 data, mechanism differences, and timeline comparison.
CagriSema vs Wegovy
CagriSema vs Wegovy: 22.7% vs 15% weight loss. Should you wait for CagriSema or start Wegovy now? FDA timeline, cost outlook, and clinical data.
Ozempic vs Mounjaro
Ozempic vs Mounjaro head-to-head comparison. Compare A1C reduction, weight loss, cost, side effects, and cardiovascular data. Find which GLP-1 is right for you.
Wegovy vs Mounjaro
Wegovy vs Mounjaro comparison for weight loss. Compare efficacy, cost, side effects, and FDA approval status. Find which injection is right for your weight loss journey.
Vyvanse vs Concerta
Compare Vyvanse (lisdexamfetamine) and Concerta (methylphenidate ER) for ADHD treatment. Explore differences in duration, onset, side effects, cost, and more.
Strattera vs Qelbree
Compare Strattera (atomoxetine) and Qelbree (viloxazine ER) for ADHD. Explore differences in mechanism, onset, side effects, cost, and which non-stimulant is right for you.
Yaz vs Beyaz
Compare Yaz and Beyaz birth control pills: both contain drospirenone and ethinyl estradiol, but Beyaz includes folate. Learn about differences in cost, indications, and benefits for pregnancy planning.
Mirena vs Kyleena
Compare Mirena and Kyleena IUDs: both are hormonal, T-shaped, and FDA-approved for 5 years. Mirena delivers more levonorgestrel and treats heavy periods; Kyleena has a smaller device and lower hormone dose.
Nurtec vs Qulipta
Compare Nurtec ODT (rimegepant) and Qulipta (atogepant) for migraine. Both are oral CGRP antagonists (gepants), but Nurtec treats acute attacks and prevents them, while Qulipta is preventive-only.
Aimovig vs Emgality
Compare Aimovig (erenumab) and Emgality (galcanezumab) for migraine prevention. Both are monthly injectable CGRP monoclonal antibodies, but they target different parts of the CGRP pathway.

Research without missing the move

Get the important GLP-1 updates, not more noise

We’ll send the high-signal stuff only: pricing changes, shortages, and new switch guidance worth acting on.

  • Price and access changes
  • New medication comparisons
  • Actionable switch guidance

No spam. Unsubscribe anytime. We never share your email.